Development and validation of an automated chemiluminometric immunoassay for human intrinsic factor antibodies in serum

Clinical Chemistry

Volumn 51, Issue 1, 2005, Pages 232-235

  Gomez, Elizabeth A ^a   Ehresmann, Daniel D ^a   Ledebuhr, Lisa K ^b   Eastvold, Mary L ^b   Singh, Ravinder ^b   Klee, George G ^b   Grebe, Stefan K G ^b  

^a Beckman Coulter Inc   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; COBALAMIN; CYANOCOBALAMIN; HETEROPHILE ANTIBODY; INTRINSIC FACTOR; INTRINSIC FACTOR ANTIBODY; PEPSIN A; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; AUTOMATION; BINDING SITE; CHEMILUMINOMETRIC IMMUNOASSAY; CYANOCOBALAMIN DEFICIENCY; HUMAN; IMMUNOASSAY; METHODOLOGY; PERNICIOUS ANEMIA; STOMACH ACID; VALIDATION PROCESS;

AUTOANALYSIS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHEMILUMINESCENT MEASUREMENTS; FEMALE; HUMANS; IMMUNOASSAY; INTRINSIC FACTOR; MALE; REFERENCE VALUES; SERUM; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 11144334592     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2004.043133     Document Type: Article

References (12)

1. 12 and folate deficiency: a guide for the primary care physician. Arch Intern Med 1999;159:1289-98.
2. Klee GG. Cobalamin and folate evaluation: measurement of methylmalonic acid and homocysteine vs vitamin B12 and folate. Clin Chem 2000;46:1277-83.
3. 12 deficiency as a worldwide problem. Annu Rev Nutr 2004;24:299-326.
4. Carmel R. Current concepts in cobalamin deficiency. Annu Rev Med 2000;51:357-75.
5. 12 concentrations. J Am Geriatr Soc 2002;50:146-51.
6. 12 deficiency. Clin Lab Med 2002;22:435-45.
7. Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med 1996;156:1097-100.
8. 12 binding capacity of transcobalamin I and II of normal human serum. Scand J Haematol 1968;5:64-74.
9. 12 levels. Am J Clin Pathol 1984;82:300-4.
10. Dawson DW, Fish DI, Frew ID, Roome T, Tilston I. Laboratory diagnosis of megaloblastic anaemia: current methods assessed by external quality assurance trials. J Clin Pathol 1987;40:393-7.
11. Nimo RE, Carmel R. Increased sensitivity of detection of the blocking (type I) anti-intrinsic factor antibody. Am J Clin Pathol 1987;88:729-33.
12. Waters HM, Smith C, Howarth JE, Dawson DW, Delamore IW. New enzyme immunoassay for detecting total, type I, and type II intrinsic factor antibodies. J Clin Pathol 1989;42:307-12.